Sarepta Therapeutics Inc (SRPT)
113.91
+3.41
(+3.09%)
USD |
NASDAQ |
Nov 22, 12:07
Sarepta Therapeutics Total Assets (Quarterly): 3.600B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.600B |
| June 30, 2024 | 3.424B |
| March 31, 2024 | 3.224B |
| December 31, 2023 | 3.265B |
| September 30, 2023 | 3.110B |
| June 30, 2023 | 3.126B |
| March 31, 2023 | 3.060B |
| December 31, 2022 | 3.128B |
| September 30, 2022 | 3.156B |
| June 30, 2022 | 2.997B |
| March 31, 2022 | 3.056B |
| December 31, 2021 | 3.148B |
| September 30, 2021 | 2.662B |
| June 30, 2021 | 2.759B |
| March 31, 2021 | 2.765B |
| December 31, 2020 | 2.985B |
| September 30, 2020 | 2.781B |
| June 30, 2020 | 2.883B |
| March 31, 2020 | 2.947B |
| December 31, 2019 | 1.823B |
| September 30, 2019 | 1.702B |
| June 30, 2019 | 1.748B |
| March 31, 2019 | 1.964B |
| December 31, 2018 | 1.642B |
| September 30, 2018 | 1.183B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.247B |
| March 31, 2018 | 1.300B |
| December 31, 2017 | 1.308B |
| September 30, 2017 | 800.28M |
| June 30, 2017 | 450.14M |
| March 31, 2017 | 511.53M |
| December 31, 2016 | 424.10M |
| September 30, 2016 | 487.31M |
| June 30, 2016 | 204.07M |
| March 31, 2016 | 213.36M |
| December 31, 2015 | 273.78M |
| September 30, 2015 | 184.75M |
| June 30, 2015 | 231.71M |
| March 31, 2015 | 242.71M |
| December 31, 2014 | 295.03M |
| September 30, 2014 | 319.06M |
| June 30, 2014 | 337.31M |
| March 31, 2014 | 275.39M |
| December 31, 2013 | 291.57M |
| September 30, 2013 | 304.48M |
| June 30, 2013 | 183.63M |
| March 31, 2013 | 193.34M |
| December 31, 2012 | 204.99M |
| September 30, 2012 | 53.08M |
| June 30, 2012 | 42.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.823B
Minimum
Dec 2019
3.600B
Maximum
Sep 2024
2.995B
Average
3.058B
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 772.01M |
| Madrigal Pharmaceuticals Inc | 1.073B |
| Vertex Pharmaceuticals Inc | 22.24B |
| Viking Therapeutics Inc | 937.89M |
| Regenxbio Inc | 519.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.379B |
| Shareholders Equity (Quarterly) | 1.221B |
| Debt to Equity Ratio | 1.005 |
| Current Ratio | 3.839 |
| Net Debt Paydown Yield | 0.01% |